Traderboersenboard - Einzelnen Beitrag anzeigen

Starlight · 06-10-2004, 21:32

Genentech beats by $0.03 , ups Y04 guidance (DNA) : Reports Q3 (Sep) earnings of $0.24 per share, ex items, $0.03 better than the Reuters Estimates consensus of $0.21; revenues rose 46.9% year/year to $1.2 bln vs the $1.2 bln consensus. Company issues in-line guidance for Y04 (Dec), sees EPS of $0.80-0.83 vs. Reuters Estimates consensus of $0.80. Previous co guidance called for $0.75-0.80.

06-10-2004, 21:32	#2
Starlight TBB Family Registriert seit: May 2002 Beiträge: 34.578	Genentech beats by $0.03 , ups Y04 guidance (DNA) : Reports Q3 (Sep) earnings of $0.24 per share, ex items, $0.03 better than the Reuters Estimates consensus of $0.21; revenues rose 46.9% year/year to $1.2 bln vs the $1.2 bln consensus. Company issues in-line guidance for Y04 (Dec), sees EPS of $0.80-0.83 vs. Reuters Estimates consensus of $0.80. Previous co guidance called for $0.75-0.80.